Several studies have revealed the pathologic roles of eATP and purinergic receptors (especially P2X7) in the development of intestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) [1, 34] (Table 1). Here, P2RX1 is linked to irritable bowel syndrome.